Israeli based company hopes to fill the void on Baby Formula. Waiting on FDA

ATHENS, GEORGIA - May 12, 2022 : Infant baby formula product shortage. Empty Similac baby food shelves at an American grocery store supermarket (courtesy: Shutterstock)

Rev 6:6 NAS “And I heard something like a voice in the center of the four living creatures saying, “A quart of wheat for a denarius, and three quarts of barley for a denarius; and do not damage the oil and the wine.”

Important Takeaways:

  • ISRAELI FIRM COMMITS TO SHIPPING 200,000 CANS OF BABY FORMULA TO US TO HELP SOLVE CRISIS
  • An Israeli-based company hopes to fill the void
  • Three weeks ago, the U.S. Food and Drug Administration issued emergency guidance enabling the import of infant formulas produced abroad.
  • Tel Aviv-based MyOr—an Israeli health-tech company—is among companies seeking FDA approval as its Mexican subsidiary, AlphaCare, produces and markets MyOr formulas from a plant in north-central Mexico.
  • “We have 200,000 cans of formula ready to be shipped right now, with a capacity to produce another 250,000 a month,” said MyOr co-founder and chief technology officer Michael Brandwein.
  • Founded in 2018, MyOr provides preventive health-care solutions for infants at-risk with a specific focus on food allergies and nutritional sufficiency.

Read the original article by clicking here.

Leave a Reply

To have your avatar appear when commenting, please signup for the Gravatar service. Your email address will not be published.

 characters available

To have your avatar appear when commenting, please signup for the Gravatar service.